ALYSSA BOWER: Open Payments
NPI 1770345456 · HENRICO, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 50 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,402 · 2025 $1,516
Food & beverage: $1,417Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $328 |
| Arcutis Biotherapeutics, Inc. | 4 | $191 |
| Incyte Corporation | 7 | $167 |
| GENZYME CORPORATION | 4 | $166 |
| Janssen Biotech, Inc. | 5 | $158 |
| Galderma Laboratories, L.P. | 3 | $137 |
| Amgen Inc. | 3 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| UCB, Inc. | 3 | $62 |
Products named: SKYRIZI, DUPIXENT, Zoryve, Opzelura, TREMFYA, NEMLUVIO, OTEZLA, COSENTYX.
Industry payments across VA — which companies pay providers there.
